Franklin Resources, Inc. 13D and 13G filings for Heron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-06 11:43 am Sale |
2023-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
FRANKLIN RESOURCES INC BEN |
6,404,795 4.300% |
-5,462,985 (-46.03%) |
Filing |
| 2023-01-31 1:12 pm Sale |
2022-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
FRANKLIN RESOURCES INC BEN |
11,867,780 10.000% |
-99,685 (-0.83%) |
Filing |
| 2022-02-03 3:01 pm Sale |
2021-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
FRANKLIN RESOURCES INC BEN |
11,967,465 11.700% |
-721,237 (-5.68%) |
Filing |
| 2021-02-01 2:39 pm Purchase |
2020-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
FRANKLIN RESOURCES INC BEN |
12,688,702 14.000% |
327,291 (+2.65%) |
Filing |